AJ

Ashley Jarvis

AT Ark Therapeutics: 2 patents #7 of 28Top 25%
II Imperial College Innovations: 2 patents #28 of 353Top 8%
IH Institute Of Cancer Research: Royal Cancer Hospital: 2 patents #33 of 148Top 25%
VI Vertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
Overall (All Time): #598,443 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12247045 MAP4K4 inhibitors Michael SCHNEIDER, Gary Karl Newton, Kathryn Chapman, Rehan Aqil, Tifelle REISINGER +4 more 2025-03-11
11795169 MAP4K4 inhibitors Michael SCHNEIDER, Gary Karl Newton, Katie CHAPMAN, Trevor Robert Perrior, Caroline Minli Rachel Low +8 more 2023-10-24
9611223 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use Alan Ashworth, Christopher James Lord, Richard James Rowland Elliott, Dan Niculescu-Duvaz, Roderick Alan Porter +8 more 2017-04-04
9193689 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use Alan Ashworth, Christopher James Lord, Richard James Rowland Elliot, Dan Niculescu-Duvaz, Roderick Alan Porter +5 more 2015-11-24
8455497 Inhibitors of aspartyl protease Michael Hale, Roger D. Tung, Stephen Price, Robin Wilkes, Wayne C. Schairer +7 more 2013-06-04
8227606 Arginine derivatives with NP-1 antagonistic activity Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman +6 more 2012-07-24
8158789 Arginine derivatives with NP-I antagonistic activity Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman +6 more 2012-04-17
6878728 Inhibitors of aspartyl protease Michael Hale, Roger D. Tung, Stephen Price, Robin Wilkes, Wayne C. Schairer +6 more 2005-04-12